Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.

Author: BalaskasElias V, GeorgianosPanagiotis I, KyriakouAndreas, LiakopoulosVassilios, LiampasIoannis, RaptisVasilios, SavvidisNikolaos, SioulisAthanasios, VaiosVasilios, ZebekakisPantelis E

Paper Details 
Original Abstract of the Article :
Sodium polystyrene sulfonate (SPS) is a cation-exchanging resin that has been widely used for several decades as first-line therapy of mild chronic hyperkalemia in patients with chronic kidney disease (CKD). However, evidence to prove the long-term tolerability and efficacy of SPS for the treatment ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s11255-017-1717-5

データ提供:米国国立医学図書館(NLM)

Sodium Polystyrene Sulfonate: A Long-Term Evaluation for Hyperkalemia in CKD

Hyperkalemia, a condition characterized by high potassium levels in the blood, can be a significant challenge for individuals with chronic kidney disease (CKD). Sodium polystyrene sulfonate (SPS), a cation-exchange resin, is a widely used treatment for mild chronic hyperkalemia. However, evidence regarding its long-term efficacy and tolerability is lacking. This study aimed to address this knowledge gap and evaluate the long-term use of SPS in CKD patients.

SPS: A Reliable Long-Term Treatment Option for Hyperkalemia in CKD

The study provides valuable information about the long-term use of SPS in CKD patients. The results suggest that SPS is both effective and well-tolerated for long-term management of mild chronic hyperkalemia. The findings offer reassurance for clinicians and patients seeking a reliable treatment option for this common condition.

Navigating the Desert of CKD Management: Understanding Long-Term Treatment Options

The study highlights the importance of understanding long-term treatment options for managing hyperkalemia in CKD. It provides valuable data that can help clinicians make informed decisions about the most appropriate treatment approach for individual patients. It’s like discovering a hidden spring in the desert – a reliable source of water that can help sustain life in a challenging environment.

Dr. Camel's Conclusion

This study provides valuable insights into the long-term tolerability and efficacy of sodium polystyrene sulfonate for managing hyperkalemia in patients with chronic kidney disease. The researchers' findings suggest that SPS can be a reliable and well-tolerated treatment option, providing a valuable resource for clinicians and patients alike. In the challenging landscape of CKD management, SPS emerges as a promising solution for controlling hyperkalemia, helping patients navigate the desert of chronic kidney disease with greater confidence.
Date :
  1. Date Completed 2018-07-20
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

29027620

DOI: Digital Object Identifier

10.1007/s11255-017-1717-5

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.